McGill Alert / Alerte de McGill

Updated: Mon, 07/15/2024 - 16:07

Gradual reopening continues on downtown campus. See Campus Public Safety website for details.

La réouverture graduelle du campus du centre-ville se poursuit. Complément d'information : Direction de la protection et de la prévention.

Theophylline

 

mcg/ml

mMol/L

     

therapeutic level

10 to 20

55.5 to 111

toxic level

>20

>111

     

action levels

   

MDAC

>20

>111

HP (acute od)

>90

>500

HP (chronic od)

>40

>222

Approach

1) Hx - Is it possible ?

total amt (mg/kg) = dose / (kg) (Vd) = 9000 mg / (60 kg) (.5 L/kg) = 300 mg/L

assumes 100 % bioavalability and asorption, no immediate metabolism

good for ic boluses, overestimates po dose

2) Are the signs and symptoms suggestive ?

- GI-nausea, vomiting because stimulates Chemotactic Trigger Zone; good marker,if no Sx then question the diagnosis

- Tachycardia,dysrhythmias, hypotension

- Tremors, Seizures

Mechanism of Action

1) phosphodiesterase inhibitor - increases cAMP in overdose only, not with therapeutic doses - smooth muscle relaxant, CNS excitation

2) adenosine antagonist - adenosine modulates histamine release to cause bronchoconstriction

3) catecholamine release - increases circulating catecholamines (EPI > NE )

4) diuretic

5) stimulates diaphraghm

Clinical Effects

- nausea, protracted vomiting

- Seizures - phosphodiesterase inhibition, adenosine antagonist, catecholamine release

- CNS - anxiety, hyperventilation, tremor, agitation, hypereflexia

- hypotension - phosphodiesterase sm relaxation, catecholamine (B2) release, diuretic

intravascular vol depleted - n,v, diuretic, diaphoresis

- tachycardias - sinus, SVT, VT - if absent question Dx or consider mixed od

- cardiac - catecholamines, hypoK, hypoPO4, acidosis

- lytes - hypoK, hypoMg, hypoPO4, increase/decrease Ca++

hyperglycemia

Anion Gap Metabolic Acidosis (lactate)

respiratory alkalosis (confused with ASA)

increase WBC

- K+ shifts intracellularly

K pump stimulus is cAMP and B receptor

Treatment

- stabilize ABC’s

- consider DONT for AMS

- cardiac monitor, NIBP

- no Ipecac - have vomited enough, leads to protracted vomiting

- lavage - if have not vomited, tablets don’t fit but a little removal may be beneficial

- Charcoal - require 10:1, large doses often require (500 g), may not keep down due to nausea and vomiting

- MDAC - multi-dose activated charcoal (may need antiemetic, ng drip)

50 g (without sorbitol) Q1H if significant Sx or rising serum levels

50 g Q2H if clinically stable

GI dialysis effect - trapping with back diffusion or sink effect with passive diffusion, creates diffusion gradient from blood to bowel lumen

- Whole Bowel Irrigation (WBI) - if worsening with increasing levels despite charcoal, or with sustained release tabs

Hemodialysis/ Hemoperfusion

Serum theophylline levels Q1H

Persistant vomiting

- common with theophylline

- metochlorpromide

does not decrease Sz threshold

promotility in small bowel

up to 1 mg/kg may be required (dystonia at higher doses)

- phenothiazines - avoid due to decrease in Sz threshold, decrease in GI motility

- Zofran (Odansetron) - 5-HT inhibitor

- slow charcoal ng drip for MDAC

-WBI

- HP indicated after 3rd dose of metochlorpromide

SVT

1) Beta blocker - esmolol relatively B1, less likely to cause bronchospasm

2) CCB

3) Adenosine generally ineffective in therapeutic doses (adenosine inhibitor)

- check lytes and correct K+, Mg++

Seizures

- chemstrip and D50W if low

- Benzo - Benzo - barbs -Propafol - GA - NMB

- avoid Dilantin - doesn’t work in toxic induced Sz (increased Sz in mouse model, not effective in a rabbit model)

- Hemoperfusion

- intubate and lavage

Persistant hypotension

1) volume

2) vasodilation - pure alpha agonist (may decrease HR) theophylline already has excessive beta activity

3) trial of B blocker (? due to predominantly B2 effects) - works in dog model

use SG monitoring (vasodilation, negative ionotrope, volume depletion, rate)

4) Hemoperfusion, lavage, ETT

Dysrhythmias

- correct hypoK,

- CCB for SVT, lidocaine for VT

Hemoperfusion

- indications - level of 40 mcg/ml(mg%)with following

Sz

hypotension

rhythym disturbance

level of 90 mg%

level > 70 mg% four hours after ingestion of sustained release

rising levels despite Rx (4 doses), can’t tolerate charcoal, severe underlying disease

protracted vomiting despite antiemetics

- must be hemodynamically stable and able to tolerate heparin, if you wait until dysrhythmias and hypotension then you have waited too long

- may require fluids and vasopressors to maintain BP

- charcoal cartridge will remove 33 % of PLT (monitor them)

- hypoCa++ common with HP

- continue oral charcoal q1h (continued absorption from the gut)

- HP > HD > PD

- complications - hypotension, hemolysis, thrombocytopenia, charcoal embolus, local line complications

- arrange for early transfer if in peripheral hospital

Indications for ICU Admission

- large quantity ingested, potentially lethal quantity

- Seizures

- ventricular dysrhythmia

- hypotension

- abnormal Vital Signs or Mental Status

- theophylline level not declining

- clinical symptoms cannot be explained solely by theophylline level

Chronic intoxication

- sicker at lower levels (40 - 60 mcg/ml)

- MAT, A fib due to underlying disease

- Seizures at lower levels

- lack of electrolyte abnormalities (K, acidosis)

- cardiac toxicity due to overstimulation of myocardium, hypoxia, lytes

Back to top